Together we will beat cancer


Stopping the spread: A revolution in how we think about metastasis

Research from our Cambridge Institute has shown us that metastasis isn’t a process unique to cancer, revolutionising the way we think about cell dissemination. 

Read More

NICE doesn’t recommend olaparib for patients with certain prostate cancers

NICE does not recommend olaparib (Lynparza) for people with a type of advanced prostate cancer, as the treatment is not deemed cost-effective

Read More

Why haven’t we cured cancer?

This entry is part 4 of 6 in the series Cancer Revolutionaries

Despite big improvements in survival, cancer is still one of the world’s biggest killers. Leading scientists explain why it presents such a challenge – and look at how far we’ve come

Read More

Inside Cancer Grand Challenges Part 1: what makes a grand challenge?

This entry is part 1 of 2 in the series Inside Cancer Grand Challenges

Today, Cancer Grand Challenges announced four new teams that have each received £20 million in funding to take on the biggest challenges in cancer research

Read More

Picking out the patterns: How scientists are finding cancer’s signatures in tumour DNA

An international team of researchers have identified 21 common faults in cancer DNA using an algorithm that works similarly to Netflix

Read More

Stem cell research: meet the scientist growing ‘mini guts’ in her lab

This entry is part 1 of 6 in the series Cancer Revolutionaries

Vivian Li, group leader of the stem cell and cancer biology lab at the Francis Crick Institute, talks tumours and how she aims to target them.

Read More

Disease in a dish: Mini-gut organoids and the challenges of bowel cancer

Disrupted cell signalling, hijacked stem cells and the power of ‘mini-guts’ – we hear from Dr Vivian Li on the challenges and opportunities of developing colorectal cancer treatments.

Read More

Taking on DNA repair to tackle cancer

Pioneering therapeutics targeting the damage repair mechanism of DNA polymerase theta in a range of cancers have entered human trials – we tell the story from discovery to translation.

Read More

Unravelling the mystery of Barrett’s oesophagus

Barrett’s oesophagus affects around 1 in every 100 to 200 people in the UK, and, for a small number of people, can develop into oesophageal cancer. But the origins of the condition have remained a mystery for decades, until now.

Read More

How cancer hijacks cell death: a new view of metastasis

Professor Jody Rosenblatt tells us why dysregulated cell death could have an impact not only on metastasis, but also therapy resistance.

Read More